FABIUS GS PREMIUM 8607000

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a company representative,user f report with the FDA on 2020-03-31 for FABIUS GS PREMIUM 8607000 manufactured by Dr?gerwerk Ag & Co. Kgaa.

Event Text Entries

[185658069] The investigation was started; the results will be provided in a follow-up report.
Patient Sequence No: 1, Text Type: N, H10


[185658070] It was initially reported, that the customer complained because the device did not offer o2 to the patient, leading to hypoxia. Further information was received 2020-03-30: the customer reported that the hypoxia led to bradycardia and to crp. It was further reported that the patient died.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number9611500-2020-00104
MDR Report Key9902380
Report SourceCOMPANY REPRESENTATIVE,USER F
Date Received2020-03-31
Date of Report2020-03-31
Date of Event2020-03-11
Date Mfgr Received2020-03-25
Device Manufacturer Date2009-01-31
Date Added to Maude2020-03-31
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional0
Initial Report to FDA0
Report to FDA3
Event Location3
Manufacturer G1DR
Manufacturer StreetMOISLINGER ALLEE 53-55
Manufacturer CityL 23542
Manufacturer CountryGM
Manufacturer Postal Code23542
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameFABIUS GS PREMIUM
Generic NameANESTHESA UNITS
Product CodeBSZ
Date Received2020-03-31
Model NumberNA
Catalog Number8607000
Lot NumberNA
OperatorHEALTH PROFESSIONAL
Device AvailabilityY
Device Eval'ed by MfgrN
Device Sequence No1
Device Event Key0
ManufacturerDR?GERWERK AG & CO. KGAA
Manufacturer AddressMOISLINGER ALLEE 53-55 L?BECK 23542 GM 23542


Patients

Patient NumberTreatmentOutcomeDate
101. Death 2020-03-31

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.